GlassScriptPhysician profile
Scott Ronhovde
NPI 1689059248
$1,384.84
in general payments reported to CMS, 2019-2025
16 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $18.40 · 2021: $175 · 2022: $277 · 2023: $344 · 2024: $198 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $274.53 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Glaukos Corporation | $273.61 | 2022-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Allergan, INC. | $117.72 | 2021 | |
| Bausch & Lomb Americas INC. | $108.05 | 2022-2024 | |
| Maculogix, INC. | $107.56 | 2019 | |
| Apellis Pharmaceuticals, INC. | $91.59 | 2023 | Syfovre |
| Sight Sciences, INC. | $89.07 | 2023 | Tearcare System |
| Abbvie INC. | $87.52 | 2023-2024 | Lumigan, Alphagan P, Vuity |
| Alcon Vision LLC | $79.44 | 2019-2025 | Precision7 |
| Rxsight INC | $76.99 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Dompe US, INC. | $19.66 | 2024 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $14.27 | 2021 | |
| Oyster Point Pharma, INC. | $13.86 | 2022 | |
| Shire North American Group INC | $13.62 | 2019 | |
| Biotissue Holdings INC. | $13.51 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $3.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Ronhovde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.